Business Wire

Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature

CAMBRIDGE, England--(BUSINESS WIRE)--Divide & Conquer (“D&C”), a biotechnology company formed in 2018 with a £10 million (approximately $13.1 million) Series A financing from Medicxi. has left stealth ...
American Enterprise Institute

The Marriage Divide: How and Why Working-class Families Are More Fragile Today

This research brief offers an updated portrait of the class divide in American family life, finding that less than half of poor Americans age 18 to 55 (just 26 percent) and 39 percent of working-class ...
Nature

Diversity and evolution of class 2 CRISPR–Cas systems

CRISPR–Cas systems form two major classes that differ in the organization of their effector modules. The effector modules of class 2 systems consist of a single large protein, which makes them the ...